Literature DB >> 24457279

Reference interval for the index of coronary microvascular resistance.

Ole Geir Solberg1, Asgrimur Ragnarsson, Anita Kvarsnes, Knut Endresen, Erik Kongsgård, Svend Aakhus, Lars Gullestad, Knut Stavem, Lars Aaberge.   

Abstract

AIMS: The index of microvascular resistance (IMR) is a relatively new tool that is used to assess microvascular function during routinely performed left heart catheterisations. In order to establish a reference interval for IMR, we investigated a subset of arrhythmia patients with structurally normal hearts and no or minimal coronary artery disease. METHODS AND
RESULTS: Physiological variables, including IMR, were measured in 20 otherwise healthy patients aged 40-60 years (10 males and 10 females) who had been referred for electrophysiological evaluation of suspected atrioventricular nodal re-entry tachycardia. IMR values were non-normally distributed with a median value of 12.6. We established a reference interval, that would be relevant to 95% of the population, of 7.3 (90% CI: 6.6-8.0) - 27.2 (90% CI: 20.8-33.7), using Box-Cox transformation and the robust Horn method. Spearman's rank correlation analysis revealed no significant relationship between IMR and several different variables.
CONCLUSIONS: A reference interval for IMR was established in a population of patients aged 40-60 years with structurally normal hearts, considered to be representative of the general population. IMR was not related to sex, age or any of the other variables tested, suggesting that this reference range can be applied to the general population.

Entities:  

Mesh:

Year:  2014        PMID: 24457279     DOI: 10.4244/EIJV9I9A181

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  8 in total

1.  Index of microcirculatory resistance: state-of-the-art and potential applications in computational simulation of coronary artery disease.

Authors:  Yingyi Geng; Xintong Wu; Haipeng Liu; Dingchang Zheng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

2.  Thrombus aspiration in STEMI revisited: impact on coronary microcirculation?

Authors:  Georg M Fröhlich; Ulf Landmesser
Journal:  Open Heart       Date:  2015-06-17

3.  Index of Microcirculatory Resistance Measured during Intracoronary Adenosine-Induced Hyperemia.

Authors:  Irene Santos-Pardo; Patrik Alström; Nils Witt
Journal:  J Interv Cardiol       Date:  2020-05-12       Impact factor: 2.279

Review 4.  Pathophysiologic Basis and Diagnostic Approaches for Ischemia With Non-obstructive Coronary Arteries: A Literature Review.

Authors:  Bingqi Fu; Xuebiao Wei; Yingwen Lin; Jiyan Chen; Danqing Yu
Journal:  Front Cardiovasc Med       Date:  2022-03-17

Review 5.  A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

Authors:  Alexandra Bastiany; Christine Pacheco; Tara Sedlak; Jaqueline Saw; Steven E S Miner; Shuangbo Liu; Andrea Lavoie; Daniel H Kim; Martha Gulati; Michelle M Graham
Journal:  CJC Open       Date:  2022-05-04

Review 6.  MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.

Authors:  Lucas Lentini Herling de Oliveira; Vinícius Machado Correia; Pedro Felipe Gomes Nicz; Paulo Rogério Soares; Thiago Luis Scudeler
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

7.  High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease.

Authors:  David C Tong; Robert Whitbourn; Andrew MacIsaac; Andrew Wilson; Andrew Burns; Sonny Palmer; Jamie Layland
Journal:  Front Cardiovasc Med       Date:  2018-01-12

Review 8.  Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.

Authors:  Thomas J Ford; Peter Ong; Udo Sechtem; John Beltrame; Paolo G Camici; Filippo Crea; Juan-Carlos Kaski; C Noel Bairey Merz; Carl J Pepine; Hiroaki Shimokawa; Colin Berry
Journal:  JACC Cardiovasc Interv       Date:  2020-08-24       Impact factor: 11.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.